Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Surrozen Inc (SRZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Surrozen's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
9.550 -0.600    -5.91%
18/05 - Closed. Currency in USD ( Disclaimer )
  • Volume: 7,727
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 9.300 - 9.940
Type:  Equity
Market:  United States
Surrozen 9.550 -0.600 -5.91%

Surrozen Inc Company Profile

 
Get an in-depth profile of Surrozen Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

42

Equity Type

ORD

Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California.

Contact Information

Address 171 Oyster Point Boulevard Suite 400
South San Francisco, 94080
United States
Phone 650 489 9000
Fax -

Top Executives

Name Age Since Title
Craig C. Parker 61 2018 CEO, President & Director
Shao-Lee Lin 56 2021 Independent Director
Eric H. Bjerkholt 63 2023 Independent Director
Mace L. Rothenberg 66 2021 Independent Director
Scott L. Friedman - 2022 Member of Scientific Advisors
Sarah Gillmor Hymowitz - 2022 Member of Scientific Advisors
Willard H. Dere 70 - Member of Scientific Advisors
Wen-Chen Yeh 60 2016 Member of Scientific Advisory Board
Bart Williams - - Member of Scientific Advisors
David J. Woodhouse 53 2020 Independent Chairman of the Board
Harold Eliot Varmus - - Member of Scientific Advisors
Mary Haak-Frendscho 67 2021 Independent Director
Timothy W. Kutzkey 48 2016 Independent Director
Anna Berkenblit 54 2018 Independent Director
Christopher Y. Chai 57 2021 Independent Director
Calvin Kuo - - Co-Founder & Member of Scientific Advisor
K. Christopher Garcia - - Co-Founder & Member of Scientific Advisory Board
Roeland Nusse 74 - Co-Founder & Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SRZN Comments

Write your thoughts about Surrozen Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email